Preview

Scott Deter And Ventria Case Study Summary

Good Essays
Open Document
Open Document
459 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Scott Deter And Ventria Case Study Summary
The problem facing Scott Deeter and Ventria was denied the request to plant rice om a commercial scale, Deeter was facing the challenge to find the best way the inexperienced, high risk, investor supported company was going to meet their mission statement of being able to provide affordable human health products for the global community. In addition the company faced ongoing protest from various groups including environmentalist, food safety activist, consumer activist, and rice farmers.
The original stake holder in Ventria was Dr. Raymond Rodrigues and the students of the University of California-Davis who had garnered a grant for the commercialization of the basic scientific research providing the useful proteins in rice plants being extracted and purified to use in harvesting organs or tissues, and to commercialize his techniques for producing medical proteins …show more content…
William Rutter, founder and board chairman of the Emeryville biotechnology firm Chiron to his new venture. Rutter invested. The group providing 85 percent of the company’s financing were board members which were comprised of Rutter, Dr. Pablo Valenzuela, cofounders of Chiron Corporation; William H. Rutter, Attorney and Venture; Ron Vogel, President of Great Western Malting; Dr. Roberto Crea, Bio-Entrepreneur; Thomas N. Urban, Former Chairman and CEO of Pioneer Hi-Bred International Inc.; Melvin Booth, Former CEO of MedImnune; William Crouse, General Partner of Health Care Ventures; and David Dwyer, General Partner in Vista Ventures. A dialog between Ventria and its stakeholders offered the options of prioritizing their long list of projects to the one or two with the greatest likelihood of successful commercialization. Analyzing the medical activate proteins to determine which would be which would be a more successful use for the company. Didn’t meet the demonstrated need was there other company’s already proving this particular product and the methods of
Continue Reading
View Writing Issues

You May Also Find These Documents Helpful

  • Powerful Essays

    Acctg 642: Case 10-1, Solvgen Inc.
    • 1100 Words
    • 5 Pages

    Acctg 642: Case 10-1, Solvgen Inc.

    Direct Drugs Inc. (Direct) has created a plan for the acquisition of SolvGen Inc. (SolvGen), which is a publicly owned company. Direct has engaged an audit team to review agreement and procedures dealing with two separate material agreements. The first agreement is a research and development agreement and the second is a licensing and distribution agreement. The contract states that SolvGen entered into a five year research and development agreement with Careway Pharma Inc. on January 1, 2010. The agreement states that SolvGen will use its best efforts to develop a proprietary instrument system. They are expected to be ready for launch in the near future. SolvGen and Careway also entered in an agreement for a five year license and distribution. This agreement was entered in on January 1, 2010 as well. The terms of the research and development agreement state that SolvGen holds all intellectual rights that correspond with the research and development of the contract. Also with this agreement SolvGen is entitled to nonrefundable milestone payments from Careway and they are as follows:…

    • 1100 Words
    • 5 Pages
    Powerful Essays
    Read More
  • Satisfactory Essays

    Cetuximab Case Study
    • 316 Words
    • 2 Pages

    Cetuximab Case Study

    Our company want to major in follow on biologics of bifunctional antibodies. The bifunctional antibodies market is still infancy and certainly first companies enter to this flied will have a competitive advantage over other biopharma companies. Therefor, we want to be one of the first companies starting in the field of follow on bifunctional antibodies. Nonetheless, many big pharma companies attracted to biosimilar market since they are in patent cleft thus they are trying to collaborate with other companies to produce biosimilar. For example, Pfizer established a collaborative with Biocon to produce biosimilar for insulin. As a new company, Innovace want to collaborate with biopharma company in China to magnify our business and brand name so then we can stand in the biosimilar…

    • 316 Words
    • 2 Pages
    Satisfactory Essays
    Read More
  • Good Essays

    Plant Nutrients Inc
    • 1399 Words
    • 6 Pages

    Plant Nutrients Inc

    Plant Nutrients Inc. (PNI) is operating in an industry requiring constant innovation in order to combat declining prices. In the case of PNI, it is critical that Brian Dunwoodie acknowledge where the company’s competitive advantage lies, and continue to leverage PNI’s ability to sell to small farms well. PNI should incorporate a seed business into its current business model through a strategic partnership with Larson Seeds, giving PNI the ability to offer a complete agronomic input package. The addition of a seed business will position PNI for continued success with small farms, as well as provide a tool to grow their business with medium farms, which account for the majority of crop production in PNI’s market area. This decision satisfies the performance standards set by Plant Nutrients International, the parent company, of 2% yearly sales growth and a 13% ROI (See Ex.3 for projected financial performance).…

    • 1399 Words
    • 6 Pages
    Good Essays
    Read More
  • Good Essays

    Golden Rice Rhetorical Analysis
    • 1477 Words
    • 6 Pages

    Golden Rice Rhetorical Analysis

    On August 8, 2013, a field of rice, called “Golden Rice”, was completely devastated by a group of angry Filipino protestors. However, this was no ordinary rice. It was genetically modified rice that was designed to alleviate some major problems in the world. One farmer passionately said, “we do not want our people, especially our children, to be used in these experiments.” However, there were several people outraged by this act of vandalism. One of those people, Amy Harmon, decided to bury the notion that Golden Rice is detrimental to human health. She attempted this difficult task in her article, “Golden Rice: Lifesaver?” I will be analyzing how she conveys her message to the readers of the article in this rhetorical analysis essay. I argue…

    • 1477 Words
    • 6 Pages
    Good Essays
    Read More
  • Powerful Essays

    Beta-Galactosidase and Western Blot
    • 4130 Words
    • 118 Pages

    Beta-Galactosidase and Western Blot

    Roe, S. (2001). _Protein Purification Techniques: A Practical Approach_ (2nd Ed.). United Kingdom: Oxford University Press…

    • 4130 Words
    • 118 Pages
    Powerful Essays
    Read More
  • Satisfactory Essays

    Ventria Bioscience Case Study
    • 428 Words
    • 2 Pages

    Ventria Bioscience Case Study

    1. The problem facing Scott Deeter and his company Ventria is that CRC advisory board and California Secretary of Agriculture is not being convinced to allow Ventria start planting genetically modified Rice in California.…

    • 428 Words
    • 2 Pages
    Satisfactory Essays
    Read More
  • Better Essays

    Nucleon Case
    • 1217 Words
    • 5 Pages

    Nucleon Case

    Nucleon, Inc. is one of over 200 firms founded since the 1970s which are focused on developing biotechnological pharmaceuticals products. Biotechnology came about with the development in advances of molecular biology and immunology, hence the new field of R&D is called “biotechnology”. Nucleons first product is CRP-1 (cell regulation ein-1) and after several years of experimentation the time was ready for human clinical trials, which was not going to be an easy hurdle to get over. Due to the fact that Nucleon did not have any manufacturing facilities which met the FDA requirements they had to figure out how to jump over the hurdles presented. One potion was to contract clinical manufacturing to an outside firm. Another option was to build a new pilot plant for clinical trials. Nucleons third option is to license the manufacturing to another biotechnology company. Risk was found in their options but they also came with rewards. If Nucleon could establish a strong paten on a important molecule this could ensure capital for growth and development which could keep Nucleon alive for years.…

    • 1217 Words
    • 5 Pages
    Better Essays
    Read More
  • Satisfactory Essays

    Amgen’s Epogen
    • 541 Words
    • 3 Pages

    Amgen’s Epogen

    Amgen first went after product patent, the strongest type of patent. But Amgen knew that it would be very difficult to get the product patent because it did not pass the test of “non-obviousness in the light prior art”. Therefore they also went after process patent. Now to increase the protection, Amgen also patented the starting material that is needed to produce EPO protein i.e. host cell and its vector.…

    • 541 Words
    • 3 Pages
    Satisfactory Essays
    Read More
  • Good Essays

    Pros And Cons Of The Revolutionary War
    • 511 Words
    • 3 Pages

    Pros And Cons Of The Revolutionary War

    Looking at the images on Page 100, These two pictures contribute to the debate on the question of African influences in American rice production because they exemplify how African workers produce rice a century later with the same tools. African slaves could teach English planters by showing them their traditional methods of rice…

    • 511 Words
    • 3 Pages
    Good Essays
    Read More
  • Powerful Essays

    Ventria Bioscience Case
    • 1029 Words
    • 5 Pages

    Ventria Bioscience Case

    In this paper I am writing on the Ventria Bioscience and the Controversy over Plant-Made Medicines Case. Ventria Bioscience is a company that is trying to commercialize pharmaceuticals made from genetically modified plants. While Ventria is gaining opposition from regulators, activist, and environmentalist; they could succeed if they use their relevant stakeholders and specific strategies, information, financial incentive, constituency building, to influence regulators.…

    • 1029 Words
    • 5 Pages
    Powerful Essays
    Read More
  • Good Essays

    Reflective Essay: The Master Cleanse
    • 748 Words
    • 3 Pages

    Reflective Essay: The Master Cleanse

    The author answers the question “How do I get My Protein” in the following way.…

    • 748 Words
    • 3 Pages
    Good Essays
    Read More
  • Powerful Essays

    Nestle Fairtrade Analysis
    • 2496 Words
    • 10 Pages

    Nestle Fairtrade Analysis

    Management 's objective is to improve the quality of products, at the same time, Improve the life quality of farmers in Ethiopia and El Salvador by reducing the uncertainty. With a transparent supply chain and quality control at the grass root level, company wishes to expand profits in the ethical market segment.…

    • 2496 Words
    • 10 Pages
    Powerful Essays
    Read More
  • Good Essays

    Document
    • 668 Words
    • 3 Pages

    Document

    The scientist make the proteins by giving the rabbits the transgenic genes, then in the rabbit the genes make the rabbits produce the proteins in their milk, and then they milk the rabbits and purify the proteins out of the milk. (pg 67)…

    • 668 Words
    • 3 Pages
    Good Essays
    Read More
  • Good Essays

    Biology
    • 543 Words
    • 3 Pages

    Biology

    4. The scientists make the animals develop the desired proteins by, putting original human genes in to the animals causing them to express certain human therapeutic proteins in their milk. The scientists access the proteins by, giving the animals the genes, then they milk the animals and purify the proteins out of the milk, and lastly have the proteins made into different medical applications. (Page 66-67)…

    • 543 Words
    • 3 Pages
    Good Essays
    Read More
  • Best Essays

    Industry Analysis of Nucleon, Inc.
    • 4924 Words
    • 20 Pages

    Industry Analysis of Nucleon, Inc.

    Founded in 1985 by Dr. Alan Ball, Nucleon’s vision was to develop pharmaceutical products based on a class of proteins known as cell regulating factors. Although CRP-1 (Nucleon’s first product) was a naturally occurring protein contained in human blood plasma, the amount that could be extracted was far too small to be of any commercial use. For that reason, from 1985 to 1988, Dr. Ball and a small group of scientists researched ways of producing CRP-1 outside the human body. After extensive research, it was indicated that CRP-1 had potential as a treatment for burns and for kidney failure.[i]…

    • 4924 Words
    • 20 Pages
    Best Essays
    Read More